MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	7.18B
Revenue (ttm)	807.00M
Net Income (ttm)	223.08M
Shares Out	575.97M
EPS (ttm)	0.39
PE Ratio	32.26
Forward PE	24.17
Dividend	0.22 (1.80%)
Ex-Dividend Date	Sep 10, 2025

Volume	5,148,000
Average Volume	13,338,269
Open	12.52
Previous Close	12.46
Day's Range	12.24 - 12.93
52-Week Range	8.22 - 19.06
Beta	-0.15
RSI	55.19
Earnings Date	Mar 26, 2026

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 522
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2024, MicroPort NeuroScientific's revenue was 761.76 million, an increase of 14.44% compared to the previous year's 665.62 million. Earnings were 254.17 million, an increase of 74.63%.

Financial numbers in CNY